Records containing: Ulcerative Colitis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-04-27A Phase 2b, Open-label, Efficacy and Safety Study of ABX464 as Maintenance Therapy in Patients With Moderate to Severe Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2025-04-22IBD-Sleep: A Pilot Study Looking at Changes in Sleep Timing and IBD Symptoms
-
CLINICAL_TRIALS study record update · 2025-04-18A LOW-INTERVENTIONAL, PROSPECTIVE, MULTI-CENTER STUDY TO EVALUATE REAL-WORLD CLINICAL, BIOCHEMICAL AND PATIENT-REPORTED RESPONSES TO TOFACITINIB INDUCTION THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS IN SWITZERLAND
-
CLINICAL_TRIALS study record update · 2025-04-15Evaluation of the Small Intestine Microbiome Aspiration (SIMBA) Capsule for Small Intestinal Dysbiosis
-
CLINICAL_TRIALS study record update · 2025-04-13A Comparative Evaluation of Different Histopathological Indices of Mucosal Healing in Ulcerative Colitis, and Their Correlation With Clinical Follow-up Data
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-04-09Pro-active Fecal Calprotectin Monitoring to Improve Patient Outcomes in Ulcerative Colitis: A Prospective Randomised Control Trial
-
CLINICAL_TRIALS study record update · 2025-04-06The Fibre Study: RCT of Personalized Fibre Diet in IBD
-
CLINICAL_TRIALS study record update · 2025-04-02A Pilot Study Evaluating Immunogenicity of Herpes Zoster Subunit Vaccine in Inflammatory Bowel Disease Patients Treated With Vedolizumab
-
CLINICAL_TRIALS study record update · 2025-04-02Efficacy and Safety of Carotegrast Methyl in Active Ulcerative Colitis: A Real-World Prospective Cohort Study
-
CLINICAL_TRIALS study record update · 2025-04-02Efficacy of Microbiome Manipulation Strategies Fecal Microbial Transplant or Anti-inflammatory Diet or Both With Advanced Therapies BiOlOgics and Small Molecules to Break the Therapeutic Ceiling in Active Ulcerative Colitis BOOST-UC A Multicenter Double Blind Factorial Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2025-03-26A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of Oral Ozanimod to Evaluate Efficacy and Long-term Safety in Chinese Participants With Moderately to Severely Active Ulcerative Colitis (UC)
-
CLINICAL_TRIALS study record update · 2025-03-25Genome Analysis Across Populations in Inflammatory Bowel Disease
-
CLINICAL_TRIALS study record update · 2025-03-24A Phase 1b, Randomized, Adaptive, Double-Blind, Placebo-Controlled, Multicenter Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Doses of PT101 in Subjects With Active Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2025-03-21Infliximab BS for Intravenous Drip Infusion 100 mg "Pfizer" General Investigation (Crohn's Disease or Ulcerative Colitis)
-
CLINICAL_TRIALS study record update · 2025-03-17Effect of Tofacitinib on Coagulation and Platelet Function, and Its Role in Thromboembolic Events
-
CLINICAL_TRIALS study record update · 2025-03-17Identification of Predictive Biomarkers for Response to Biologic Therapies and Tofacitinib in Inflammatory Bowel Disease by Proteomic and Mass Cytometry Approaches
-
CLINICAL_TRIALS study record update · 2025-03-14Ibd CAncer and seRious Infections in France (I-CARE 2)
-
CLINICAL_TRIALS study record update · 2025-03-14Spatially and Temporally Resolving Predictive Biomarkers of Postoperative Recurrence and Complications in Chronic Intestinal Inflammation
-
CLINICAL_TRIALS study record update · 2025-03-12The Application of Transcriptomics for Establishing Potential Prognostic Markers of Response to Treatment of Ulcerative Colitis With Ustekinumab
-
CLINICAL_TRIALS study record update · 2025-03-12Assessing Gut Microbiota, Mucosal Healing Markers, and Metabolites in Mild to Moderate Ulcerative Colitis Treated With Multi-Strain Probiotics
-
CLINICAL_TRIALS study record update · 2025-03-10Veränderungen Des Faecalen Calprotectinwertes Und Teilhabebezogener Scores in Folge Einer Dreiwöchigen Phase II Rehabilitation [Changes in Faecal Calprotectin Levels and Participation-related Scores Following Three Weeks of Inpatient Rehabilitation]
-
CLINICAL_TRIALS study record update · 2025-03-05Understanding Local TReatment Patterns and Outcomes With upAdacitinib in IBD Patients in Belgium
-
CLINICAL_TRIALS study record update · 2025-03-05Phase 2a, Double-Blind, Randomized Adaptive Design, Placebo-Controlled, Parallel Group Study to Evaluate the Safety, Tolerability, Efficacy, PK and Biomarkers with Oral Colon Delivery PL8177 in Adult Subjects with Active Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2025-03-05Clinical Study Evaluating the Possible Beneficial Effect of Silymarin in Patients With Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2025-03-05A Follow-up Phase IIa Study to Evaluate the Long-term Safety and Efficacy Profile of ABX464 Given at 50 mg Once Daily in Subjects With Moderate to Severe Active Ulcerative Colitis.